Charles River Laboratories (CRL) Tops Q2 EPS by 32c, Lifts Guidance
Tweet
Share
E-mailGet Alerts CRL Hot Sheet
Price: $280.05 --0%
Financial Fact:
Net sales related to products: 132.87M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Net sales related to products: 132.87M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Charles River Laboratories (NYSE: CRL) reported Q2 EPS of $1.58, $0.32 better than the analyst estimate of $1.26. Revenue for the quarter came in at $682.6 million versus the consensus estimate of $641.63 million.
GUIDANCE:
Charles River Laboratories sees FY2020 EPS of $7.05-$7.35, versus the consensus of $6.91.
- Revenue growth, reported 7.5% – 9.0%
For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- Seritage Growth Properties (SRG) Reports Q2 Loss of $0.13
- Vislink Technologies Inc. (VISL) Misses Q2 EPS by 7c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
